ENZO BIOCHEM, INC. — Operating Income by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/1544134a-4a1d-4a8a-8083-9a1ebe5219c1/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-12.4M | 2023-08-01 – 2024-07-31 | evidence 0001213900-24-091798 |
| FY 2023 | $-24.7M | 2022-08-01 – 2023-07-31 | evidence 0001213900-23-083566 |
| FY 2022 | $-17.0M | 2021-08-01 – 2022-07-31 | evidence 0001213900-23-083566 |
| FY 2021 | $692.0k | 2020-08-01 – 2021-07-31 | evidence 0001213900-21-052364 |
| FY 2020 | $-30.4M | 2019-08-01 – 2020-07-31 | evidence 0001213900-20-032066 |
| FY 2019 | $1.7M | 2018-08-01 – 2019-07-31 | evidence 0000930413-19-002691 |
| FY 2018 | $-12.2M | 2017-08-01 – 2018-07-31 | evidence 0000930413-18-003072 |
| FY 2017 | $-3.1M | 2016-08-01 – 2017-07-31 | evidence 0000930413-18-003072 |
| FY 2016 | $46.8M | 2015-08-01 – 2016-07-31 | evidence 0000930413-18-003072 |
| FY 2015 | $-1.2M | 2014-08-01 – 2015-07-31 | evidence 0000930413-15-003965 |
| FY 2014 | $-10.2M | 2013-08-01 – 2014-07-31 | evidence 0000930413-14-004315 |
| FY 2013 | $-19.0M | 2012-08-01 – 2013-07-31 | evidence 0000930413-13-004942 |
| FY 2012 | $-40.5M | 2011-08-01 – 2012-07-31 | evidence 0000930413-12-005743 |
| FY 2011 | $-12.9M | 2010-08-01 – 2011-07-31 | evidence 0000930413-12-005743 |
| FY 2010 | $-22.1M | 2009-08-01 – 2010-07-31 | evidence 0000930413-12-005743 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).